Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Laboratoires BIOLIGO

Nil


Contact Details:
Z.I. De l'AsseChemin de la Vuarpilliere 25
NYON
1260
Switzerland
Tel:41 22 365-62-62
Fax:41 22 365-62-00
Email:info@bioligo.ch
WWW:

www.bioligo.ch/




BioNews Results for Laboratoires BIOLIGO:

Impax Laboratories Confirms Patent Challenge Relating to TRICOR 48mg and 145mg Tablets
Pharma Live:  Nov 2 2009 9:49PM Matching: laboratoires
Impax Laboratories Confirms Patent Challenge Relating to TRICOR 48mg and 145mg Tablets
SmartBrief:  Oct 31 2009 2:00AM Matching: laboratoires
Impax Laboratories Confirms Patent Challenge Relating to TRICOR 48mg and 145mg Tablets
Pharmacy Choice:  Oct 30 2009 10:34PM Matching: laboratoires
Impax Laboratories Confirms Patent Challenge Relating to TRICOR 48mg and 145mg Tablets
Genetic Engineering News:  Oct 30 2009 3:57PM Matching: laboratoires
Impax Laboratories Confirms Patent Challenge Relating to TRICOR 48mg and 145mg Tablets
Yahoo! Canada:  Oct 30 2009 3:51PM Matching: laboratoires
Promote your company here: BioNewsCast - Press Release Distribution

View more Laboratoires BIOLIGO news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 297 times since April 2007, the link to the organisation's website has been followed 60 times

Search for more companies in NYON

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Laboratoires BIOLIGO

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.